Science Daily: Pharmacology News
MAY 10, 2024
Many artificial intelligence (AI) systems have already learned how to deceive humans, even systems that have been trained to be helpful and honest. Researchers describe the risks of deception by AI systems and call for governments to develop strong regulations to address this issue as soon as possible.
BioPharma Drive: Drug Pricing
MAY 10, 2024
Interim data surpassed expectations, iTeos said. Elsewhere, Acelyrin revealed chief executive officer Shao-Lee Lin is departing and Bluebird bio gave a fuller account of its gene therapy launches.
Science Daily: Pharmacology News
MAY 10, 2024
Many neurons exhibit 'mixed selectivity,' meaning they can integrate multiple inputs and participate in multiple computations. Mechanisms such as oscillations and neuromodulators recruit their participation and tune them to focus on the relevant information.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Opal Sandy was born into a world she could not hear. The British baby girl, now 18 months old, had a rare genetic condition called auditory neuropathy that interrupted nerve impulses that travel from the inner ear to.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
MAY 10, 2024
The regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.About 6% are taking one right now, the poll found.Most patients say they use the.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- When cancer strikes, you could easily go into debt, even with health insurance in place, according to a new survey from the American Cancer Society.The survey, based on responses from nearly 1,300 cancer patients and.
Collaborative Drug
MAY 10, 2024
Hooray for curve overlays!! We are excited to announce a new round of features associated with our Curve Analytics Module. If you are not yet subscribed to Curve Analytics, please contact your CDD Vault account manager or the CDD Vault Support Team to discuss enabling these features in your Vault.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- H5N1 avian flu is now infecting U.S. dairy cows and the federal government on Friday announced a myriad of initiatives aimed at preventing the virus' mutation and spread in humans. The illness is typically not fatal in.
Science Daily: Pharmacology News
MAY 10, 2024
Astronomers have proposed a new theory to explain the origin of phosphorus, one of the elements important for life on Earth. The theory suggests a type of stellar explosion known as ONe novae as a major source of phosphorus.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Happily jumping around lawn sprinklers or playing with garden hoses on a hot summer day: An idyllic childhood scene.Not so for a bunch of kids in Utah, who all got serious E. coli illnesses from the contaminated water they.
Conversations in Drug Development Trends
MAY 10, 2024
By: Christine Moore, PhD, Vice President, Neuroscience, Scientific Solutions Patients with borderline personality disorder (BPD) face a heightened risk of substance abuse and suicide, as well as substantial delays in receiving treatment. Despite these risks, there are no medications specifically approved to target the core symptoms of BPD; current treatments are limited to managing underlying affective symptoms.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Ascension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our.
BioPharma Drive: Drug Pricing
MAY 10, 2024
Sanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination influenza vaccines.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- For 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. Then a routine physical turned up anomalies in his blood work that turned his life upside down."The labs came back irregular.
Agency IQ
MAY 10, 2024
BY LAURA DIANGELO, MPH The National Institute of Standards and Technology (NIST) last week released four new documents on artificial intelligence, mostly focusing on generative AI (GAI). The documents seek to both expand NIST’s existing frameworks to directly address the unique aspects of GAI and outline the novel questions still to be addressed in this field.
Cytel
MAY 10, 2024
In this latest edition of our Career Perspectives series, we had the privilege of interviewing Emily Woolley, Senior Director of Biostatistics at Axio, a Cytel company, residing in Oregon, USA. With over a decade of experience in clinical trial statistics and serving as an independent statistician for numerous trials, Emily brings a wealth of expertise and insights.
Agency IQ
MAY 10, 2024
BY WALKER LIVINGSTON, ESQ States across the U.S. have been introducing and enacting legislation to restrict or remediate PFAS at a breakneck pace, with varying approaches and models. This AgencyIQ analysis reviews recently proposed or enacted legislation, with an eye to understanding how these models could be implemented more broadly. Per- and polyfluoroalkyl substances are a large group of synthetic organic chemicals used in many different industrial, commercial, and consumer applications since
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Quanticate
MAY 10, 2024
A Data Safety Monitoring Board (DSMB) plays a critical role in ensuring the safety, credibility, and integrity of ongoing clinical trials. Comprising independent professionals with relevant expertise, the DSMB regularly reviews data accumulated from one or more ongoing clinical trial. The DSMB continuously advises the sponsor on the safety of trial subjects and those yet to be recruited to the trial as well as the validity and scientific merit of the trial.
Agency IQ
MAY 10, 2024
BY LAURA DIANGELO, MPH Almost three years after the initial draft, the FDA has now finalized guidance describing the differences between medical device “servicing” and “remanufacturing” and each activity’s quality system implications. The new guidance maintains the agency’s existing definitions of remanufacturing and servicing, but adds a new section that provide a high level overview of the medical device regulations – primarily for those “less familiar.
BioPharma Drive: Drug Pricing
MAY 10, 2024
An alliance with Shionogi involves similar terms as a deal Sanofi canceled in response to an unusual challenge from the Federal Trade Commission.
Agency IQ
MAY 10, 2024
BY COREY JASEPH, MS, RAC The European Ombudsman recently updated its investigation into the complaint that the Commission reclassified brain stimulation devices without a thorough look at the scientific evidence. But the advice went beyond the specific instance of the reclassification regulation to suggest that the regulator needs to ensure its feedback mechanisms are robust and thorough.
Perficient: Drug Development
MAY 10, 2024
This blog is the second post in a series about leveraging user stories to improve product outcomes. In this post, we will explore how acceptance criteria can be used to define the scope and requirements of user stories. What are Acceptance Criteria? Acceptance criteria, or AC, are the minimum level of expectations that need to be met to mark a user story as complete.
Agency IQ
MAY 10, 2024
BY RAYAN BHARGAVA, MSC Though delayed due to farmer protests, the latest version of France’s longstanding pesticide reduction plan has been published. This last iteration replaces France’s own indicator of the amount and intensity of pesticide use with a metric adopted by the EU that attempts to refine human health risk assessment, but employs a controversial weighting scheme.
Perficient: Drug Development
MAY 10, 2024
Welcome to the second installment of our Universal Design Series, where we continue our exploration of the critical intersection of Equity for Learning in Education Accessibility. In this edition, we’ll delve into the principles, strategies, and significance of advancing equity through Universal Design in creating accessible and inclusive learning environments.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Telehealth is revolutionizing health care in America by making it easier than ever to reach a doctor – but not everyone is benefitting, a new study reports.People with limited English skills are more likely to have worse.
Antidote
MAY 10, 2024
Artificial intelligence, most commonly known as AI, has become a buzzword across many industries. While it is most commonly used in relation to art generators or web searches, AI has many practical applications beyond these uses — especially within the clinical trial marketing space. The global market size of AI-based clinical trial marketing is expected to reach nearly 8 billion by 2031 , mainly due to the extensive advancements in the medical field.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- A quick swish at the doctor’s office could someday provide early detection of stomach cancer, the fourth-leading cause of cancer deaths worldwide, a new study reports.Researcher found distinct differences in bacteria.
thought leadership
MAY 10, 2024
In January 2024, the FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products issued a guidance document- Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products. This long-awaited guidance provides guardrails which allow CAR T product developers and manufacturers to focus efforts for consistent expectations rather than relying on perspective review of prior approvals.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Robot-assisted total knee replacements tend to have better outcomes on average, a new study reports.Unfortunately, there’s a downside – having a surgical robot assist a human surgeon can make the procedure much more.
Drug Patent Watch
MAY 10, 2024
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Drugs.com
MAY 10, 2024
FRIDAY, May 10, 2024 -- Steve Murray, 68, has spent a lot of time out in the sun, at work and at play.Murray worked construction for several decades, and as a child spent summers on the beach in Ocean City, N.J., and enjoyed winter visits to sunny.
Drug Patent Watch
MAY 10, 2024
Annual Drug Patent Expirations for PONVORY Ponvory is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier.
Expert insights. Personalized for you.
139 
Let's personalize your content